{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T01:28:19Z","timestamp":1649208499874},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[1988,5,1]],"date-time":"1988-05-01T00:00:00Z","timestamp":578448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1988,5]]},"DOI":"10.1007\/bf01745513","type":"journal-article","created":{"date-parts":[[2005,6,14]],"date-time":"2005-06-14T01:01:35Z","timestamp":1118710895000},"page":"437-442","source":"Crossref","is-referenced-by-count":3,"title":["Kaposi's sarcoma in AIDS patients: Long-term treatment with recombinant interferon alpha-2A and chemotherapy"],"prefix":"10.1007","volume":"66","author":[{"given":"M.","family":"Flepp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"T\u00e4uber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"L\u00fcthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Siegenthaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01745513_CR1","first-page":"305","volume":"25","author":"Centers for Disease Control","year":"1981","unstructured":"Centers for Disease Control (1981) Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men \u2014 New York City and California. MMWR 25:305\u2013308","journal-title":"MMWR"},{"key":"BF01745513_CR2","first-page":"373","volume":"34","author":"Centers for Disease Control","year":"1985","unstructured":"Centers for Disease Control (1985) Revision of case definition of acquired immunodeficiency syndrome for national reporting \u2014 United States. MMWR 34:373\u2013374","journal-title":"MMWR"},{"key":"BF01745513_CR3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7326\/0003-4819-100-1-92","volume":"100","author":"AS Fauci","year":"1984","unstructured":"Fauci AS, Macher AM, Longo DL, et al. (1984) NIH Conference: Acquired immunodeficiency syndrome: Epidemiologic, clinical, immunologic and therapeutical considerations. Ann Intern Med 100:92\u2013106","journal-title":"Ann Intern Med"},{"key":"BF01745513_CR4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/infdis\/152.1.162","volume":"152","author":"WR Frederick","year":"1985","unstructured":"Frederick WR, Epstein JS, Gelmann EP, et al. (1985) Viral infections and cell-mediated immunity in immunodeficient homosexual men with Kaposi's sarcoma treated with human lymphoblastoid interferon. J Infect Dis 152:162\u2013170","journal-title":"J Infect Dis"},{"key":"BF01745513_CR5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0002-9343(85)90276-1","volume":"78","author":"EP Gelmann","year":"1985","unstructured":"Gelmann EP, Preble OT, Steis R, et al. (1985) Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Am J Med 78:737\u2013741","journal-title":"Am J Med"},{"key":"BF01745513_CR6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0002-9343(87)90445-1","volume":"82","author":"EP Gelmann","year":"1987","unstructured":"Gelmann EP, Longo D, Lane HC, et al. (1987) Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immunodeficiency syndrome. Am J Med 82:456\u2013462","journal-title":"Am J Med"},{"key":"BF01745513_CR7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-100-5-671","volume":"100","author":"JE Groopman","year":"1984","unstructured":"Groopman JE, Gottlieb MS, Goodman J, et al. (1984) Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. Ann Intern Med 100:671\u2013676","journal-title":"Ann Intern Med"},{"key":"BF01745513_CR8","first-page":"602","volume":"I","author":"DD Ho","year":"1985","unstructured":"Ho DD, Hartshorn KL, Rota TR, et al. (1985) Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro. Lancet I:602\u2013604","journal-title":"Lancet"},{"key":"BF01745513_CR9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation form incomplete observations. J Am Statist Ass 53:457\u2013481","journal-title":"J Am Statist Ass"},{"key":"BF01745513_CR10","first-page":"50","volume":"10","author":"P Kern","year":"1987","unstructured":"Kern P, Meigel W, Racz P, et al. (1987) Interferon alpha in the treatment of AIDS-associated Kaposi's sarcoma. Onkologie 10:50\u201352","journal-title":"Onkologie"},{"key":"BF01745513_CR11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/1097-0142(19800201)45:3<427::AID-CNCR2820450304>3.0.CO;2-1","volume":"45","author":"E Klein","year":"1980","unstructured":"Klein E, Schartz RA, Laor Y, et al. (1980) Treatment of Kaposi's sarcoma with vinblastine. Cancer 45:427\u2013431","journal-title":"Cancer"},{"key":"BF01745513_CR12","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1002\/1097-0142(197812)42:6<2626::AID-CNCR2820420618>3.0.CO;2-7","volume":"42","author":"O Klepp","year":"1978","unstructured":"Klepp O, Dahl O, Stenwig JT (1978) Association of Kaposis sarcoma and prior immunosuppressive therapy. A 5-year material of Kaposi's sarcoma in Norway. Cancer 42:2626\u20132630","journal-title":"Cancer"},{"key":"BF01745513_CR13","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJM198305053081806","volume":"308","author":"SE Krown","year":"1983","unstructured":"Krown SE, Real FX, Cunningham-Rundles S, et al. (1983) Preliminary observations on the effect of recombinant leukocyte interferon in homosexual men with Kaposi's sarcoma. N Engl J Med 308:1071\u20131076","journal-title":"N Engl J Med"},{"key":"BF01745513_CR14","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/1097-0142(19860415)57:8+<1662::AID-CNCR2820571305>3.0.CO;2-Y","volume":"57","author":"SE Krown","year":"1986","unstructured":"Krown SE, Real FX, Vadhan-Raj S, et al. (1986) Kaposi's sarcoma and the acquired immune deficiency syndrome. Cancer 57:1662\u20131665","journal-title":"Cancer"},{"key":"BF01745513_CR15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/1097-0142(19800215)45:4<684::AID-CNCR2820450411>3.0.CO;2-U","volume":"45","author":"TCM Lo","year":"1980","unstructured":"Lo TCM, Salzman FA, Smedal MI, Wright MS (1980) Radiotherapy for Kaposi's sarcoma. Cancer 45:684\u2013687","journal-title":"Cancer"},{"key":"BF01745513_CR16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207\u2013214","journal-title":"Cancer"},{"key":"BF01745513_CR17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-102-2-200","volume":"102","author":"DM Mintzer","year":"1985","unstructured":"Mintzer DM, Real FX, Jovino L, et al. (1985) Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome. Ann Intern Med 102:200\u2013202","journal-title":"Ann Intern Med"},{"key":"BF01745513_CR18","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/1097-0142(19860415)57:8+<1657::AID-CNCR2820571304>3.0.CO;2-N","volume":"57","author":"RT Mitsuyasu","year":"1986","unstructured":"Mitsuyasu RT, Taylor JMG, Glaspy J, Fahey JL (1986) Heterogeneity of epidemic Kaposi's sarcoma. Cancer 57:1657\u20131661","journal-title":"Cancer"},{"key":"BF01745513_CR19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/1097-0142(19860415)57:8+<1685::AID-CNCR2820571310>3.0.CO;2-0","volume":"57","author":"R Ohno","year":"1986","unstructured":"Ohno R, Kimura K (1986) Treatment of multiple myeloma with recombinant interferon alfa-2a. Cancer 57:1685\u20131686","journal-title":"Cancer"},{"key":"BF01745513_CR20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/bjc.1976.220","volume":"34","author":"R Peto","year":"1976","unstructured":"Peto R, Pike MC, Armitage P, et al. (1976) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 34:585\u2013612","journal-title":"Br J Cancer"},{"key":"BF01745513_CR21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1200\/JCO.1986.4.4.544","volume":"4","author":"FX Real","year":"1986","unstructured":"Real FX, Oettgen HF, Krown SE (1986) Kaposi's sarcoma and the acquired immunodeficiency syndrome: Treatment with high and low doses of recombinant leucocyte A interferon. J Clin Oncology 4:544\u2013551","journal-title":"J Clin Oncology"},{"key":"BF01745513_CR22","first-page":"62","volume":"10","author":"B Safai","year":"1980","unstructured":"Safai B, Good RA (1980) Kaposi's sarcoma: A review and recent developments. Clin Bull 10:62\u201369","journal-title":"Clin Bull"},{"key":"BF01745513_CR23","doi-asserted-by":"crossref","first-page":"744","DOI":"10.7326\/0003-4819-103-5-744","volume":"103","author":"B Safai","year":"1985","unstructured":"Safai B, Johnson KG, Myskowski PL, et al. (1985) The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med 103:744\u2013750","journal-title":"Ann Intern Med"},{"key":"BF01745513_CR24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.7326\/0003-4819-96-1-80","volume":"96","author":"ER Stiehm","year":"1982","unstructured":"Stiehm ER, Kronenberg LH, Rosenblatt HM, et al. (1982) UCLA conference. Interferon: Immunobiology and clinical significance. Ann Intern Med 96:80\u201393","journal-title":"Ann Intern Med"},{"key":"BF01745513_CR25","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM198604243141701","volume":"314","author":"M Talpaz","year":"1986","unstructured":"Talpaz M, Kantarjian HM, McCredie K, et al. (1986) Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha-A in chronic myelogenous leukemia. N Engl J Med 314:1065\u20131069","journal-title":"N Engl J Med"},{"key":"BF01745513_CR26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ijc.2910080116","volume":"8","author":"JF Taylor","year":"1971","unstructured":"Taylor JF, Templeton AC, Vogel CL, Ziegler JL, Kyalwazi SK (1971) Kaposi's sarcoma in Uganda: A clinico-pathological study. Int J Cancer 8:122\u2013135","journal-title":"Int J Cancer"},{"key":"BF01745513_CR27","first-page":"2","volume":"12","author":"PA Volberding","year":"1985","unstructured":"Volberding PA, Mitsuyasu R (1985) Recombinant interferon alpha in the treatment of acquired immune deficiency syndrome-related Kaposi's sarcoma. Sem Oncol 12:2\u20136","journal-title":"Sem Oncol"},{"key":"BF01745513_CR28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/0003-4819-103-3-335","volume":"103","author":"PA Volberding","year":"1985","unstructured":"Volberding PA, Abrams DI, Conant M, et al. (1985) Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med 103:335\u2013338","journal-title":"Ann Intern Med"},{"key":"BF01745513_CR29","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/1097-0142(19870201)59:3+<620::AID-CNCR2820591309>3.0.CO;2-5","volume":"59","author":"PA Volberding","year":"1987","unstructured":"Volberding PA, Mitsuyasu RT, Golando JP, Spiegel RJ (1987) Treatment of Kaposi's sarcoma with interferon alfa-2b (Intron A) Cancer 59:620\u2013625","journal-title":"Cancer"},{"key":"BF01745513_CR30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/jir.1986.6.143","volume":"6","author":"JK Yamamoto","year":"1986","unstructured":"Yamamoto JK, Barre-Sinoussi F, Bolton V, et al. (1986) Human alpha- and beta-interferon but not gamma-suppress the in vitro replication of LAV, HTLV-III, and ARV-2. J Interferon Res 6:143\u2013152","journal-title":"J Interferon Res"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01745513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01745513\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01745513","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T11:07:31Z","timestamp":1557313651000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01745513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,5]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1988,5]]}},"alternative-id":["BF01745513"],"URL":"https:\/\/doi.org\/10.1007\/bf01745513","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,5]]}}}